MedTrace Logo

Clinical Study of TripleA for Treatment of Alcohol Addiction in Outpatient Care

NCT03195894 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2021-12-13

Study results available
· View outcomes & findings →

Summary

The primary objective is to investigate differences in the alcohol consumption pattern between alcohol addicts receiving conventional treatment and those who receive a combination of conventional treatment and TripleA.

Conditions

  • Alcoholism

Interventions

DEVICE

TripleA

Sponsors & Collaborators

  • Uppsala University

    collaborator OTHER

  • Kontigo Care AB

    lead INDUSTRY

Principal Investigators

  • Tobias Eriksson, MD PhD · Uppsala University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-01
Primary Completion
2018-02-15
Completion
2018-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03195894 on ClinicalTrials.gov